On february 5, 2019, the lay user/patient contacted lifescan (lfs) (b)(4), alleging that her onetouch select meter read inaccurately high compared to her feelings and/or normal readings.The complaint was classified based on the customer service representative (csr) documentation.The patient reported that the alleged meter inaccuracy began approximately one month prior to contacting lfs.The patient reported obtaining alleged inaccurate high blood glucose readings between ¿10.6-12.0 mmol/l¿ with the subject meter.Meter to feelings/normal results comparisons do not meet the criteria necessary for lfs to determine an inaccuracy.The patient informed the csr that she manages her diabetes with ¿2 units¿ of glimepiride in combination with diet and exercise.The patient reported that an unspecified time before the alleged inaccuracy began she had developed symptoms of ¿dizziness, feeling of falling and visual impairment¿.The patient reported that in response to the alleged inaccurate high readings obtained with the subject meter she increased her dose of medication from "2 units to 3 or 4 units" of glimepiride.The patient reported that an unspecified time after taking the increased dose of glimepiride she felt ¿worse¿ and performed another test with the subject meter and a result of ¿3.1 mmol/l¿ was obtained.The patient self-treated her symptoms with sweets and reported feeling better.During troubleshooting, the csr noted that the subject meter was set to the correct unit of measure.In addition, the csr confirmed that the patient¿s test strips had been stored correctly and were within their expiry/discard date.The patient did not have control solution to perform a quality control test.Replacement products were sent to the patient.This complaint is being reported because the patient reportedly developed symptoms suggestive of a serious injury adverse event after taking an increased dose of glimepiride in response to alleged inaccurate high results obtained with the subject meter.
|